Anna Carrasquer

Tarragona, CT 43007, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Sex Differences in Myocardial Injury: Clinical Characteristics, Outcomes, and Prognostic Implications.

Sex Differences in Myocardial Injury: Clinical Characteristics, Outcomes, and Prognostic Implications.

Journal: Journal of clinical medicine

Published: January 05, 2026

Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial.

Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial.

Journal: Circulation

Published: November 07, 2025

Patient and Physician Perspectives on Cardiovascular Risk: A Multicenter Survey of Communication Gaps Among Hospitalized Patients in Spain.

Patient and Physician Perspectives on Cardiovascular Risk: A Multicenter Survey of Communication Gaps Among Hospitalized Patients in Spain.

Journal: Circulation. Cardiovascular quality and outcomes

Published: September 08, 2025

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.

Journal: The New England journal of medicine

Published: September 01, 2025

Reply to "Growth differentiation factor 15 and empagliflozin in acute myocardial infarction: Correspondence".

Reply to "Growth differentiation factor 15 and empagliflozin in acute myocardial infarction: Correspondence".

Journal: International journal of cardiology

Published: June 08, 2025

Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2-trans,4-cisdecadienoylcarnitine levels.

Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2-trans,4-cisdecadienoylcarnitine levels.

Journal: Clinical and translational medicine

Published: April 14, 2025

Cancer and myocardial injury in patients with suspected acute coronary syndrome.

Cancer and myocardial injury in patients with suspected acute coronary syndrome.

Journal: Cardio-oncology (London, England)

Published: December 20, 2024

Growth differentiation factor 15: A biomarker to guide empagliflozin treatment in acute myocardial infarction?

Growth differentiation factor 15: A biomarker to guide empagliflozin treatment in acute myocardial infarction?

Journal: International journal of cardiology

Published: November 23, 2024

Unselected cardiac troponin testing and the diagnosis of myocardial infarction in the emergency department.

Unselected cardiac troponin testing and the diagnosis of myocardial infarction in the emergency department.

Journal: BMC emergency medicine

Published: November 23, 2024

Prognostication in emergency room patients: comparing ultrasensitive and contemporary quantification of cardiac troponin levels below the 99th percentile.

Prognostication in emergency room patients: comparing ultrasensitive and contemporary quantification of cardiac troponin levels below the 99th percentile.

Journal: Frontiers in cardiovascular medicine

Published: October 04, 2024

Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure.

Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure.

Journal: European journal of clinical investigation

Published: August 06, 2024

Sex and clinical outcomes in new-onset heart failure.

Sex and clinical outcomes in new-onset heart failure.

Journal: International journal of cardiology

Published: July 30, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026